Under the direction of the coordinating Member State referred to in Article 74(2), the Member States shall coordinate their assessment of serious adverse events and device deficiencies to determine whether to modify, suspend or terminate the performance study or whether to revoke the authorisation for that performance study.
Faoi threoir an Bhallstáit comhordúcháin dá dtagraítear in Airteagal 74(2), déanfaidh na Ballstáit comhordú ar a measúnú ar tharluithe díobhálacha tromchúiseacha agus ar easpaí ar fheistí le cinneadh a dhéanamh an ndéanfar an staidéar feidhmíochta a mhodhnú, a chur ar fionraí nó a fhoirceannadh, nó an ndéanfar an t-údarú don staidéar feidhmíochta sin a chúlghairm.